CPHI Japan 2025, an international pharmaceutical development exhibition, is set to take place in 2025. This event is expected to attract a large number of exhibitors and visitors, with a focus on showcasing the latest machinery and equipment for pharmaceutical research, development, and manufacturing. The exhibition will cover a wide range of categories, including lab equipment, manufacturing machinery, and cleanroom facilities.

The event will be divided into several zones, with the machine and device zone being particularly noteworthy. This zone will feature displays of devices and machines used in the development and manufacturing of pharmaceuticals, ranging from raw material and intermediate body research equipment to manufacturing machinery for various drug formulations. The expanded scope of this zone aims to provide visitors with a more efficient experience by covering not only lab equipment but also factory machinery.

In addition to the exhibition, there will be seminars and presentations where leading suppliers of equipment and machinery will showcase their latest products and technologies. These sessions will cover various aspects of pharmaceutical development, from the design of raw materials and intermediates to commercial production and formulation development.

To facilitate business matchmaking, a free system will be provided to help exhibitors find suitable partners based on their strategic needs. This system allows for pre-research of domestic and international suppliers of products, technologies, and outsourced services.

The exhibition is scheduled to take place in Japan, with detailed information on venue access and accommodation available for visitors. The event is organized by Infomarkets Japan Co., Ltd., which can be contacted via email or phone for further inquiries or to request exhibition materials.

CPHI Japan 2025 aims to provide a comprehensive platform for pharmaceutical manufacturers, chemical manufacturers, research institutions, universities, and other organizations involved in pharmaceutical research, development, and manufacturing.